Skip to content
Ejaculation.org

Systematic review · 2025

Treatments for postorgasmic illness syndrome: a systematic review

Ponce S, Chapalamadugu M, Levine S, Stokes C, Radillo K, Johnson O, Bronson I, Rubin RS (2025). Treatments for postorgasmic illness syndrome: a systematic review. The Journal of Sexual Medicine. doi:10.1093/jsxmed/qdaf112

Key finding
Of 14 eligible studies on POIS treatment, 12 were case reports; treatments tried included antihistamines, NSAIDs, SSRIs, hormones and immunotherapy, and no clear guideline exists. Only 18% of experts report improvement in more than 30% of patients.

Summary

Postorgasmic illness syndrome (POIS) is a rare, poorly understood condition in which people feel ill after orgasm. The authors searched PubMed, Embase and Scopus in June 2024 for clinical studies, randomised trials and case reports on POIS treatment.

Of 58 studies found, 14 met the inclusion criteria: 1 cross-sectional study, 1 cohort study and 12 case reports. Eleven papers described medicines, including antihistamines, ibuprofen and other NSAIDs, hormone replacement, steroids, SSRIs, alpha-blockers, beta-blockers, calcium channel blockers and triptans. Two described immune treatment (injections of the man's own semen, and intralymphatic allergen immunotherapy), and one described surgery. The authors note that only 18% of sexual medicine experts report symptom improvement in more than 30% of their patients.

Limitations

The evidence is almost entirely case reports, with no randomised trials, so no treatment can be called proven. Rarity and low recognition make larger studies hard.

What it means for you

There is no standard treatment for POIS yet. Specialists usually try treatments matched to the main symptoms, one at a time, and the honest expectation is partial relief rather than a guaranteed fix.